Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson’s Disease: A Case Report

In November 2012, a 72-year old patient was diagnosed with left eye wet age-related macular degeneration. The patient received three monthly intravitreal injections of ranibizumab, with complete resolution of retinal hemorrhage and edema and reinstatement of visual acuity. In May 2015, symptomatic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Trifirò, Gianluca, Marcianò, Ilaria, Cutroneo, Paola M., Spina, Edoardo, Mirabelli, Eliana, Trombetta, Costantino J., Morgante, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003275/
https://www.ncbi.nlm.nih.gov/pubmed/29937731
http://dx.doi.org/10.3389/fphar.2018.00608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003275/
https://www.ncbi.nlm.nih.gov/pubmed/29937731
http://dx.doi.org/10.3389/fphar.2018.00608

Ejemplares similares